ES3016483T3 - Stabilizing composition for bioactive materials - Google Patents

Stabilizing composition for bioactive materials Download PDF

Info

Publication number
ES3016483T3
ES3016483T3 ES13764138T ES13764138T ES3016483T3 ES 3016483 T3 ES3016483 T3 ES 3016483T3 ES 13764138 T ES13764138 T ES 13764138T ES 13764138 T ES13764138 T ES 13764138T ES 3016483 T3 ES3016483 T3 ES 3016483T3
Authority
ES
Spain
Prior art keywords
composition
drying
formulation
dry
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13764138T
Other languages
English (en)
Spanish (es)
Inventor
Moti Harel
Qiong Tang
Trisha Rice
Kimberly Jennings
Brian Carpenter
Roger Drewes
Elizabeth Raditsis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Bionutrtion Corp
Original Assignee
Advanced Bionutrtion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionutrtion Corp filed Critical Advanced Bionutrtion Corp
Application granted granted Critical
Publication of ES3016483T3 publication Critical patent/ES3016483T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/30—Puffing or expanding
    • A23P30/32—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES13764138T 2012-03-23 2013-03-22 Stabilizing composition for bioactive materials Active ES3016483T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261614994P 2012-03-23 2012-03-23
US201261642094P 2012-05-03 2012-05-03
US201261646337P 2012-05-13 2012-05-13
PCT/US2013/033505 WO2013142792A1 (en) 2012-03-23 2013-03-22 Stabilizing composition for biological materials

Publications (1)

Publication Number Publication Date
ES3016483T3 true ES3016483T3 (en) 2025-05-09

Family

ID=49223367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13764138T Active ES3016483T3 (en) 2012-03-23 2013-03-22 Stabilizing composition for bioactive materials

Country Status (18)

Country Link
EP (1) EP2827905B1 (cg-RX-API-DMAC7.html)
JP (1) JP6229188B2 (cg-RX-API-DMAC7.html)
KR (1) KR102062645B1 (cg-RX-API-DMAC7.html)
CN (2) CN114601849A (cg-RX-API-DMAC7.html)
AR (1) AR093204A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013234931B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014023234B1 (cg-RX-API-DMAC7.html)
CA (1) CA2866889C (cg-RX-API-DMAC7.html)
CL (1) CL2014002506A1 (cg-RX-API-DMAC7.html)
ES (1) ES3016483T3 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN08599A (cg-RX-API-DMAC7.html)
MX (1) MX356072B (cg-RX-API-DMAC7.html)
MY (1) MY178686A (cg-RX-API-DMAC7.html)
NZ (1) NZ628912A (cg-RX-API-DMAC7.html)
PH (1) PH12014502092B1 (cg-RX-API-DMAC7.html)
RU (1) RU2666601C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201405478VA (cg-RX-API-DMAC7.html)
WO (1) WO2013142792A1 (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140255583A1 (en) * 2013-03-06 2014-09-11 Sunny Delight Beverages Company Protein suspension as a beverage opacifier system
WO2015061789A2 (en) 2013-10-25 2015-04-30 Nch Corporation Delivery system and probiotic composition for animals and plants
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
BR112017017147B1 (pt) * 2015-02-11 2024-02-20 Prevtec Microbia Inc Processo para fornecimento de escherichia coli (e. coli) viável embebida em uma matriz na forma de uma partícula
MY194231A (en) * 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
KR102754888B1 (ko) * 2015-12-04 2025-01-13 어드밴스드 바이오뉴트리션 코프. 당을 전혀 또는 거의 함유하지 않은 안정한 건조 조성물
FR3045384B1 (fr) * 2015-12-18 2020-02-07 Institut National De La Recherche Agronomique Composition lyophilisee pour la conservation de microbiote dans son ecosysteme
MX377224B (es) * 2015-12-18 2025-03-07 Soc Des Produits Nestle S A Star Hidratacion para animales.
CN105504050A (zh) * 2016-03-03 2016-04-20 河南欧普生物科技有限公司 一种抗安卡拉病毒鸡卵黄抗体的制备方法
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
CA3019732A1 (en) 2016-04-05 2017-10-12 Nch Corporation Nutrient rich germinant composition and spore incubation method
KR20230016060A (ko) * 2016-06-14 2023-01-31 엘랑코 캐나다 리미티드 사료 첨가제를 포함하는 동물 사료 펠릿, 이의 제조 방법 및 사용 방법
PL3476226T3 (pl) 2016-06-24 2024-08-19 Yessinergy Holding S/A Kompozycja immunomodulująca i promująca wzrost oraz kontrolująca niepożądane bakterie mikrobioty jelitowej i jej zastosowanie
KR101766430B1 (ko) 2016-10-28 2017-08-08 주식회사 삼양사 올리고당을 함유하는 알룰로오스 시럽 및 그 제조방법
CN106819418A (zh) * 2017-03-27 2017-06-13 张军军 一种超高脂饲料及其制备方法
US10323226B2 (en) 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
WO2020007931A1 (en) 2018-07-04 2020-01-09 Chr. Hansen A/S Topical compositions comprising viable probiotic bacteria
BR112020026407A2 (pt) * 2018-07-04 2021-03-23 Chr. Hansen A/S composições tópicas aquosas que compreendem bactérias probióticas viáveis
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
EP3869962A1 (en) * 2018-10-26 2021-09-01 Danisco US Inc. Stable microbial composition and drying process
CN113614055B (zh) * 2018-12-07 2023-12-26 皮沃特生物股份有限公司 用于固氮微生物产品的具有提高的稳定性的聚合物组合物
WO2020130770A1 (es) * 2018-12-19 2020-06-25 Ajtzakbio S.A.P.I. De C.V. Composición probiótica de alto valor sin necesidad de cadena de frio, desarrollada para reducir el impacto ambiental, aumentar la producción y mejorar la supervivencia de larvas de camarón
WO2021055352A1 (en) * 2019-09-16 2021-03-25 Vedanta Biosciences, Inc. Methods and compositions for preserving bacteria
CA3155795A1 (en) * 2019-10-22 2021-04-29 Massachusetts Institute Of Technology Biomaterial-based compositions to deliver plant growth promoting microbes
CN110923145B (zh) * 2019-12-16 2021-07-20 天康制药(苏州)有限公司 支原体的冻干保护剂与冻干支原体及其制备方法
WO2021159068A1 (en) 2020-02-06 2021-08-12 Nch Corportion Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
US20230080017A1 (en) * 2020-02-19 2023-03-16 Zantebio Limited Coated microcapsules and methods for the production thereof
RU2746022C1 (ru) * 2020-04-03 2021-04-06 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Способ стабилизации бактериальных клеток чумного микроба перед сублимационным высушиванием
RU2736064C1 (ru) * 2020-04-03 2020-11-11 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Защитная среда для стабилизации клеток возбудителя туляремии в процессе приготовления и хранения сухих препаратов
BR112022021933A2 (pt) 2020-05-01 2022-12-13 Pivot Bio Inc Composição agrícola líquida, tecido vegetal agrícola, e, métodos para aplicar uma bactéria diazotrófica, manter uma população de uma bactéria, aumentar a produtividade da cultura vegetal agrícola, fornecer nitrogênio atmosférico, aumentar a produtividade do milho por acre, reduzir a variabilidade no campo da produtividade e melhorar a estabilidade de uma composição agrícola líquida
WO2022138631A1 (ja) * 2020-12-25 2022-06-30 株式会社林原 家畜及び／又は家禽の生産性改善方法及び腸内菌叢改善方法
JP2022102198A (ja) * 2020-12-25 2022-07-07 ライオン株式会社 内服固形剤
EP4291045A1 (en) * 2021-02-10 2023-12-20 DSM IP Assets B.V. Powderous composition(ii)
JP2024508212A (ja) * 2021-02-10 2024-02-26 ディーエスエム アイピー アセッツ ビー．ブイ． 粉末状組成物（ｉ）
CN112843328B (zh) * 2021-02-25 2022-05-13 山东大学 一种具有抑菌作用的鲍鱼壳粉/ZnO复合材料掺杂的智能水凝胶伤口敷料的制备方法
CN113621519B (zh) * 2021-08-11 2023-07-18 河南农业大学 一种复合酵母冻干保护剂
CN119255821A (zh) * 2021-08-25 2025-01-03 奥古斯汀·T·兹维纳瓦什 微生物组递送平台
JP7680784B2 (ja) * 2021-09-29 2025-05-21 中国科学院過程工程研究所 アミノ酸系ガラス、その製造方法及びその使用
CN114196579A (zh) * 2021-12-13 2022-03-18 张峰 一种建筑通风工程用的甲醛微生物净化器
CN119095583A (zh) * 2022-04-21 2024-12-06 运动-农场有限责任公司 用于活性成分的阴道内递送装置、该装置的制备方法和用途
CN116040604B (zh) * 2022-12-21 2025-04-29 天津华电南疆热电有限公司 一种用于微生物培养的碳源材料及其制备方法
CN116694581A (zh) * 2023-05-24 2023-09-05 华南农业大学 哈维氏弧菌噬菌体v-ydf132的冻干保护剂及其保藏方法
CN117256857B (zh) * 2023-07-24 2025-12-02 浙江大学 一种用于制备鱼油微胶囊的复合壁材及其制备方法与应用
WO2025055959A1 (en) * 2023-09-12 2025-03-20 Bing Biotech Limited Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
CN117247305A (zh) * 2023-09-16 2023-12-19 鲁东大学 一种促进植物根系生长的水凝胶及制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0202537A3 (en) * 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
ES2162746B1 (es) * 1999-10-21 2003-02-16 Lipotec Sa Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
PT1296656E (pt) 2000-06-27 2006-12-29 Hoffmann La Roche Processo para a preparação de uma composição
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
AU2003247337B2 (en) * 2002-04-11 2007-09-06 Medimmune, Llc Preservation of bioactive materials by freeze dried foam
EP1562623A1 (en) * 2002-09-16 2005-08-17 Kerry Group Services Ltd Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
EP1616486A1 (en) * 2004-07-13 2006-01-18 Friesland Brands B.V. Powdered compositions containing an edible oil and their use in food products
EP1973406B1 (en) * 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
JP5285617B2 (ja) * 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
JP2011507518A (ja) * 2007-12-20 2011-03-10 アボット・ラボラトリーズ 安定な栄養粉末
CA2740855A1 (en) * 2008-10-20 2010-04-29 Nestec S.A. Nutritional composition with anti-regurgitation properties
TWI468157B (zh) * 2009-04-29 2015-01-11 Intervet Int Bv 形成錠劑的方法，進行該方法的系統及包含該錠劑的包裝物
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
PL2603100T3 (pl) * 2010-08-13 2019-06-28 Advanced Bionutrition Corp. Kompozycja stabilizująca przechowywanie na sucho materiałów biologicznych

Also Published As

Publication number Publication date
KR102062645B1 (ko) 2020-01-06
IN2014DN08599A (cg-RX-API-DMAC7.html) 2015-05-22
EP2827905B1 (en) 2025-03-12
NZ628912A (en) 2016-06-24
CN114601849A (zh) 2022-06-10
CA2866889C (en) 2021-08-31
AU2013234931A2 (en) 2014-12-04
KR20140135845A (ko) 2014-11-26
JP2015517985A (ja) 2015-06-25
MX356072B (es) 2018-05-14
MY178686A (en) 2020-10-20
BR112014023234A2 (pt) 2017-06-20
EP2827905C0 (en) 2025-03-12
AR093204A1 (es) 2015-05-27
CA2866889A1 (en) 2013-09-26
BR112014023234B1 (pt) 2020-12-08
PH12014502092A1 (en) 2014-11-24
CN104244985A (zh) 2014-12-24
BR112014023234A8 (pt) 2018-01-16
MX2014011122A (es) 2014-12-05
SG11201405478VA (en) 2014-11-27
RU2666601C2 (ru) 2018-09-11
RU2014136089A (ru) 2016-05-20
CL2014002506A1 (es) 2015-01-09
AU2013234931B2 (en) 2017-12-07
WO2013142792A1 (en) 2013-09-26
AU2013234931A1 (en) 2014-09-18
PH12014502092B1 (en) 2019-11-20
EP2827905A4 (en) 2015-05-06
JP6229188B2 (ja) 2017-11-15
EP2827905A1 (en) 2015-01-28

Similar Documents

Publication Publication Date Title
ES3016483T3 (en) Stabilizing composition for bioactive materials
US10575545B2 (en) Stabilizing composition for biological materials
ES2639397T3 (es) Composición vítrea seca que comprende un material bioactivo
ES2676656T3 (es) Composición estabilizante de almacenamiento en seco para materiales biológicos
US20190045704A1 (en) Stabilizing methods for coating seeds with biological materials
CN108368474B (zh) 没有或几乎没有糖的稳定的干组合物